Package 0406-1219-01

Brand: amphetamine sulfate

Generic: amphetamine sulfate
NDC Package

Package Facts

Identity

Package NDC 0406-1219-01
Digits Only 0406121901
Product NDC 0406-1219
Product ID 0406-1219_8fdfec51-e7c0-429b-a3f4-8f5ae2679147
Description

100 TABLET in 1 BOTTLE (0406-1219-01)

Marketing

Marketing Status
Marketed Since 2021-02-28
Brand amphetamine sulfate
Generic amphetamine sulfate
Sample Package No

Linked Drug Pages (1)

Amphetamine Sulfate ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "8fdfec51-e7c0-429b-a3f4-8f5ae2679147", "openfda": {"unii": ["6DPV8NK46S"], "rxcui": ["884655", "1600695"], "spl_set_id": ["00242264-40d8-4267-a91a-727a1f088616"], "manufacturer_name": ["SpecGx LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (0406-1219-01)", "package_ndc": "0406-1219-01", "marketing_start_date": "20210228"}], "brand_name": "Amphetamine Sulfate", "product_id": "0406-1219_8fdfec51-e7c0-429b-a3f4-8f5ae2679147", "dosage_form": "TABLET", "pharm_class": ["Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]"], "product_ndc": "0406-1219", "dea_schedule": "CII", "generic_name": "Amphetamine Sulfate", "labeler_name": "SpecGx LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Amphetamine Sulfate", "active_ingredients": [{"name": "AMPHETAMINE SULFATE", "strength": "5 mg/1"}], "application_number": "ANDA213583", "marketing_category": "ANDA", "marketing_start_date": "20210228", "listing_expiration_date": "20261231"}